ES2044843T3 - Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos. - Google Patents

Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos.

Info

Publication number
ES2044843T3
ES2044843T3 ES87101354T ES87101354T ES2044843T3 ES 2044843 T3 ES2044843 T3 ES 2044843T3 ES 87101354 T ES87101354 T ES 87101354T ES 87101354 T ES87101354 T ES 87101354T ES 2044843 T3 ES2044843 T3 ES 2044843T3
Authority
ES
Spain
Prior art keywords
quinolone
antibiotics
naftiridine
preparation
ophthalmic medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87101354T
Other languages
English (en)
Inventor
Thomas F Mich
Carl L Heifetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2044843T3 publication Critical patent/ES2044843T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A ANTIBIOTICOS DE QUINOLONA Y NAFTIRIDINA UTILES PARA EL TRATAMIENTO DE INFECCIONES OCULARES POR ADMINISTRACION TOPICA.
ES87101354T 1986-02-03 1987-02-02 Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos. Expired - Lifetime ES2044843T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/825,007 US4692454A (en) 1986-02-03 1986-02-03 Opthalmic use of quinolone antibiotics

Publications (1)

Publication Number Publication Date
ES2044843T3 true ES2044843T3 (es) 1994-01-16

Family

ID=25242879

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87101354T Expired - Lifetime ES2044843T3 (es) 1986-02-03 1987-02-02 Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos.

Country Status (14)

Country Link
US (2) US4692454A (es)
EP (1) EP0235589B1 (es)
JP (1) JPS62185085A (es)
AT (1) ATE81776T1 (es)
AU (1) AU588958B2 (es)
CA (1) CA1281653C (es)
DE (1) DE3782346T2 (es)
DK (1) DK173401B1 (es)
ES (1) ES2044843T3 (es)
GR (1) GR3006180T3 (es)
IE (1) IE61017B1 (es)
NZ (1) NZ219138A (es)
PH (2) PH23722A (es)
ZA (1) ZA87164B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826985A (en) * 1986-04-25 1989-05-02 Abbott Laboratories Intermediates for preparation of racemate and optically active ofloxacin and related derivatives
US5229128A (en) * 1986-06-11 1993-07-20 Haddad Heskel M Drug delivery ophthalmic insert and method of preparing same
AU633078B2 (en) * 1989-04-04 1993-01-21 Alcon Laboratories, Inc. The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
WO1991009616A1 (en) * 1989-12-22 1991-07-11 Yale University Quinolone antibiotics encapsulated in lipid vesicles
US4992449A (en) * 1990-02-01 1991-02-12 American Cyanamid Company 7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US5130353A (en) * 1990-03-07 1992-07-14 Ppg Industries, Inc. Method for preparing photochromic plastic article
US5185390A (en) * 1990-03-07 1993-02-09 Ppg Industries, Inc. Water strippable photochromic resin composition
JPH0725747B2 (ja) * 1990-03-16 1995-03-22 エスエス製薬株式会社 キノロンカルボン酸誘導体
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
JP4756674B2 (ja) * 2000-09-05 2011-08-24 株式会社サクラクレパス 塗布具
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
JP2011520963A (ja) * 2008-05-19 2011-07-21 アルコン リサーチ， リミテッド カルボキシビニルポリマーおよびポビドンポリマーを有する医薬組成物
AR129113A1 (es) * 2022-04-22 2024-07-17 Mitobridge Inc Activadores del factor de transcripción eb y usos de estos

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963736A (en) * 1970-01-28 1976-06-15 Sumitomo Chemical Company, Limited Preparation of 1-(lower alkyl)-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acids
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
US3907808A (en) * 1971-05-17 1975-09-23 Sterling Drug Inc 1,4-Dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS5649382A (en) * 1979-09-28 1981-05-02 Dainippon Pharmaceut Co Ltd 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
US4382937A (en) * 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
JPS57145862A (en) * 1981-03-06 1982-09-09 Kyorin Pharmaceut Co Ltd Quinolinecarboxylic acid derivative
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
FR2559484B2 (fr) * 1983-07-06 1986-09-26 Provesan Sa Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
US4604401A (en) * 1984-07-20 1986-08-05 Warner-Lambert Company Antibacterial agents III
IN162769B (es) * 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
JPH0670032B2 (ja) * 1984-11-22 1994-09-07 大日本製薬株式会社 アミノピロリジン誘導体、そのエステルおよびその塩
AU578793B2 (en) * 1985-02-15 1988-11-03 Dainippon Pharmaceutical Co. Ltd. Novel 1,8-naphthyridine derivatives and processes for preparation thereof
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
JP2874664B2 (ja) * 1996-09-18 1999-03-24 日本電気株式会社 ページプリンタ

Also Published As

Publication number Publication date
PH25096A (en) 1991-02-19
IE61017B1 (en) 1994-09-07
EP0235589A3 (en) 1989-12-13
ATE81776T1 (de) 1992-11-15
CA1281653C (en) 1991-03-19
DE3782346T2 (de) 1993-03-11
DE3782346D1 (de) 1992-12-03
GR3006180T3 (es) 1993-06-21
IE870237L (en) 1987-08-03
DK52487D0 (da) 1987-02-02
EP0235589A2 (en) 1987-09-09
JPS62185085A (ja) 1987-08-13
US4851415A (en) 1989-07-25
DK173401B1 (da) 2000-09-25
EP0235589B1 (en) 1992-10-28
AU588958B2 (en) 1989-09-28
US4692454A (en) 1987-09-08
DK52487A (da) 1987-08-04
PH23722A (en) 1989-11-03
AU6750587A (en) 1987-08-06
NZ219138A (en) 1990-03-27
ZA87164B (en) 1988-07-11

Similar Documents

Publication Publication Date Title
ES2044843T3 (es) Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos.
EP0142426A3 (en) Ophthalmic formulation containing norfloxacin and related antibiotics
ITBO910476A0 (it) -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.
DE68917163D1 (de) Antibakterielle Mittel.
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DE59003994D1 (de) Substituierte 1,8-Naphthyridine.
DK0593562T3 (da) Topisk præparat indeholdende penciclovir
FR2605008B1 (fr) Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
PT89582A (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
ES2131105T3 (es) Composiciones farmaceuticas de pentapeptidos y procedimientos de uso de las mismas.
DK71880A (da) 8-aryl-5,6,7,8-tetrahydropyrazolo (3,4-b) (1,5) diazepin-1h,4h-5,7-dioner, deres fremstilling samt anvendelse som laegemidler
NO890502D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
NO891678D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
ZA902254B (en) Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 235589

Country of ref document: ES